Provided by Tiger Trade Technology Pte. Ltd.

VECTUS BIOSYSTEMS LTD

0.160
-0.010-5.88%
Volume:61
Turnover:10
Market Cap:9.90M
PE:-6.06
High:0.160
Open:0.160
Low:0.160
Close:0.170
52wk High:0.455
52wk Low:0.053
Shares:61.87M
Float Shares:22.25M
Volume Ratio:0.00
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.026
EPS(LYR):-0.033
ROE:-289.05%
ROA:-102.23%
PB:-12.28
PE(LYR):-4.79

Loading ...

Company Profile

Company Name:
VECTUS BIOSYSTEMS LTD
Exchange:
ASX
Establishment Date:
2005
Employees:
- -
Office Location:
26-34 Dunning Avenue,Unit 5, Ground Floor,Rosebery,New South Wales,Australia
Zip Code:
2018
Fax:
61 2 9697 0944
Introduction:
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. Vectus Biosystems Limited was founded in 2005 and is based in Rosebery, Australia.